|
ADHD
|
ASD
| | | |
---|
|
(n = 48)
|
(n = 164)
| | | |
---|
|
Mean (SD)
|
Mean (SD)
|
t
|
df
|
p value
|
Age (years)
|
9 (4)
|
9 (3)
|
0.01
|
210
|
0.99
|
VIQa
|
106 (16)
|
103 (18)
|
0.75
|
208
|
0.45
|
NVIQa
|
105 (14)
|
104 (17)
|
0.21
|
207
|
0.83
|
|
n (%)
|
n (%)
|
χ
2
|
df
|
p value
|
Males
|
38 (79)
|
138 (84)
|
0.65
|
1
|
0.42
|
ADOS Mod 3
|
41 (85)
|
145 (88)
|
0.31
|
1
|
0.58
|
Site
| | | | | |
UMACC
|
29 (60)
|
70 (43)
|
26.90
|
2
|
<0.001
|
UCDDC
|
9 (19)
|
88 (54)
|
CADB
|
10 (21)
|
6 (4)
|
-
ADHD attention deficit/hyperactivity disorder, ASD autism spectrum disorder, CADB Center for Autism and the Developing Brain in New York, df degrees of freedom, UCDDC University of Chicago Developmental Disorders Clinic, UMACC University of Michigan Autism and Communications Disorders Center
-
aTwo ADHD participants were missing VIQ information and three additional ADHD participants were missing NVIQ information